LYRM4 and hepatocellular carcinoma: Our previous work also showed that the mRNA and protein levels of iron–sulphur cluster biogenesis factor ISD11 were upregulated in hepatocellular carcinoma and that it could be a novel prognostic biomarker and molecular target for hepatocellular carcinoma therapy.